Mark Stoner is CEO and cofounder of BioCrowd, an AI-native capital-formation and commercialization platform for biomedical research. He brings more than 30 years of experience in enterprise technology, consulting, finance, and emerging technology, including work with Accenture, PwC, and France Telecom. He works with universities, hospitals, cancer centers, and investigators to connect promising research with milestone-based charitable and compliant investment capital. BioCrowd was a PwC Miami pitch winner, CancerX 2026 finalist, and WHX Healthcare pitch semifinalist. A cancer survivor treated with CAR-T therapy in 2024, Stoner is committed to helping promising science reach patients faster
CRDWC 2026
Keynote Presentation